Evidence map›Paper›PMID 21688038›Full record

ArticleMolecular biotechnology2012

The high-level expression of human tissue plasminogen activator in the milk of transgenic mice with hybrid gene locus strategy.

Yanrong Zhou, Yanli Lin, Xiaojie Wu, Fuyin Xiong, Yuemeng Lv, Tao Zheng, Peitang Huang, Hongxing Chen

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular biotechnology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. [Preparation of GH/tPA double transgenic mice and gene expression analysis].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2021
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yanrong ZhouCell Engineering Department, Beijing Institute of Biotechnology, Beijing 100071, China.
Yanli Lin
Xiaojie Wu
Fuyin Xiong
Yuemeng Lv
Tao Zheng
Peitang Huang
Hongxing Chen

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Transgene expression for the mammary gland bioreactor aimed at producing recombinant proteins requires optimized expression vector construction. Previously we presented a hybrid gene locus strategy, which was originally tested with human lactoferrin (hLF) as target transgene, and an extremely high-level expression of rhLF ever been achieved as to 29.8 g/l in mice milk. Here to demonstrate the broad application of this strategy, another 38.4 kb mWAP-htPA hybrid gene locus was constructed, in which the 3-kb genomic coding sequence in the 24-kb mouse whey acidic protein (mWAP) gene locus was substituted by the 17.4-kb genomic coding sequence of human tissue plasminogen activator (htPA), exactly from the start codon to the end codon. Corresponding five transgenic mice lines were generated and the highest expression level of rhtPA in the milk attained as to 3.3 g/l. Our strategy will provide a universal way for the large-scale production of pharmaceutical proteins in the mammary gland of transgenic animals.

Indexed as

AnimalsFemaleGene Expression RegulationGenetic EngineeringHumansMammary Glands, AnimalMiceMice, TransgenicMilkMilk ProteinsTissue Plasminogen ActivatorTransgenesMilk ProteinsTissue Plasminogen Activatorwhey acidic proteins

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.